It is estimated that one in five Americans has elevated levels of Lp(a), but only about 1% has been tested. Several websites ...

The U.S. Food and Drug Administration has approved Edwards Lifesciences' SAPIEN 3 platform, a transcatheter aortic valve ...

Find out why staging TAVI and PCI lowers risk in complex heart cases - read the latest insights from the ASCoP registry.

Researchers have developed cutting-edge MRI technology to diagnose a common heart problem more quickly and accurately than ever before. Aortic stenosis is a progressive and potentially fatal condition ...

After a trial shows early intervention prevents hospitalization, the US Food and Drug Administration approves transcatheter ...

The benefit of TAVR vs. clinical surveillance for patients with asymptomatic severe aortic stenosis did not vary by age. TAVR was tied to lower stroke risk in the youngest and oldest age groups.

in patients with aortic stenosis (AS), according to data from the PREFER-CMR registry. The findings are encouraging in the context of the recent approval of TAVI for patients with asymptomatic severe ...

Please provide your email address to receive an email when new articles are posted on . Electronic provider notification led to more aortic valve replacement procedures after a diagnosis of severe ...

Aortic stenosis is a progressive and potentially fatal condition, affecting an estimated 300,000 people in the UK. It affects about five per cent of 65-year-olds in the US, with increasing prevalence ...

In the EARLY TAVR trial, which informed the approval, patients with asymptomatic severe aortic stenosis were randomly assigned to either TAVR or watchful waiting. During a median follow-up of 3.8 ...